Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)

NCT02701608 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT02701608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02701608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2016
Completion date
December 4, 2024
Enrollment
162 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

infective endocarditis